Delayed anticoagulation treatment for atrial fibrillation patients increases dementia risk, study finds
May 12, 2017
A new study has found that dementia rates increase when anticoagulation treatment is delayed for patients with atrial fibrillation, the most common heart arrhythmia in the world that affects more than 2.7 million American adults.
The first-of-its-kind, large-scale study, conducted by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City, included more than 76,000 atrial fibrillation patients with no prior history of dementia who were treated with an antiplatelet or warfarin, a medication used to treat or prevent blood clots in veins or arteries.
http://www.news-medical.net/news/20170512/Delayedc2a0anticoagulation-treatmentc2a0for-atrial-fibrillation-patientsc2a0increases-dementia-risk-study-finds.aspx
